Targeting the Transient Receptor Potential Vanilloid Type 1 (TRPV1) Assembly Domain Attenuates Inflammation-induced Hypersensitivity
Author
dc.contributor.author
Flynn, Robyn
Author
dc.contributor.author
Chapman, Kevin
es_CL
Author
dc.contributor.author
Iftinca, Mircea
es_CL
Author
dc.contributor.author
Aboushousha, Reem
es_CL
Author
dc.contributor.author
Varela Lekanda, Diego
es_CL
Author
dc.contributor.author
Altier, Christophe
es_CL
Admission date
dc.date.accessioned
2015-01-05T19:18:04Z
Available date
dc.date.available
2015-01-05T19:18:04Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
J. Biol. Chem. 2014, 289:16675-16687
en_US
Identifier
dc.identifier.other
doi: 10.1074/jbc.M114.558668
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129533
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
The transient receptor potential channel vanilloid type 1
(TRPV1) is a non-selective cation channel expressed in sensory
neurons of the dorsal root and trigeminal ganglia. TRPV1 is a
polymodal channel activated by noxious heat, capsaicin, and
protons. As a sensor for noxious stimuli, TRPV1 channel has
been described as a key contributor to pain signaling. To form a
functional channel, TRPV1 subunits must assemble into
tetramers, and several studies have identified the TRPV1 C terminus
as an essential element in subunit association. Here we
combined biochemical assays with electrophysiology and imaging-based
bimolecular fluorescence complementation (BiFC)
and bioluminescence resonance energy transfer (BRET) in live
cells to identify a short motif in the C-terminal tail of the TRPV1
subunit that governs channel assembly. Removing this region
through early truncation or targeted deletion results in loss of
subunit association and channel function. Importantly, we
found that interfering with TRPV1 subunit association using a
plasma membrane-tethered peptide attenuated mechanical and
thermal hypersensitivity in two mouse models of inflammatory
hyperalgesia. This represents a novel mechanism to disrupt
TRPV1 subunit assembly and hence may offer a new analgesic
tool for pain relief.
en_US
Patrocinador
dc.description.sponsorship
This work was supported by the Heart and Stroke Foundation of Canada
and the Canadian Institute of Health Research.
Lenguage
dc.language.iso
en
en_US
Publisher
dc.publisher
The American Society for Biochemistry and Molecular Biology